Brightspire Capital Inc

BRSP remains in a Stage 3 distribution range, with price forming lower highs and trading below the 9/20/50 EMAs and 200 DMA. Repeated stalls at the short‐term EMA resistance zone highlight supply dominance and distribution risk. The medium‐term tradable bias is bearish, and the recent pullback rejection at the EMA cluster presents a timely sell opportunity in anticipation of a further breakdown.

• ↑Plans to grow loan book to ~$3.5B by end-2026 after $319M closed in Q2.
• ↑3.03% dividend yield plus strategic buybacks underpins shareholder returns.
• ↓Q2 GAAP net loss of $18.3M ($0.15/sh) from legacy asset impairments.